Brief Acceptance and Commitment Therapy for HIV-Infected At-Risk Drinkers Administrative Supplement

针对艾滋病毒感染高危饮酒者的简短接受和承诺治疗行政补充

基本信息

  • 批准号:
    10289729
  • 负责人:
  • 金额:
    $ 22.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-03-15 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

Abstract The COVID-19 pandemic has had a significant impact on the mental health and alcohol use of the United States (US) general population, and has disproportionately affected people living with HIV (PLWH). Alcohol consumption and stress are both critical factors in HIV treatment that, if unaddressed, can significantly contribute to onward transmission and poor treatment-related outcomes. Alcohol interventions for PLWH in the US have shown mixed results. One hypothesized reason for this limited success is the failure of these interventions to address the multiple overlapping problems (e.g., co-morbid mental health conditions, stress, behavioral health needs) of PLWH who are hazardous drinkers. Innovative alcohol intervention strategies that can have an impact on these multiple behavioral health needs, in a format that can be feasibly delivered in the context of HIV care, are needed, especially in the context of the COVID-19 pandemic. Brief Acceptance and Commitment Therapy (ACT) is a promising intervention for HIV-infected hazardous drinkers. ACT is a transdiagnostic treatment that uses mindfulness skills and values-guided behavioral action plans to impact a broad array of psychological symptoms. ACT has shown efficacy for treatment of anxiety, depression, chronic pain, and substance use, and is thus a promising approach for PLWH who are hazardous drinkers and coping with additional stress related to the COVID-19 pandemic. We are proposing to expand our ongoing, NIAAA- funded (R34AA026246), pilot RCT of a telephone-delivered ACT intervention for PLWH by applying for an administrative supplement in response to the Notice of Special Interest on Stress Management in Relation to COVID-19 (NOT-AT-20-011). The overall objective of this application is to use the infrastructure of our ongoing pilot RCT (NCT0397406) to collect preliminary data on the level of stress experienced by PLWH during the COVID-19 pandemic, and to determine if participants in the RCT find the stress management techniques in our ACT intervention useful and applicable for the management of COVID-related stress. The specific aims are as follows: Aim 1: Incorporate objective and self-reported measures of stress into the pilot RCT. We will accomplish this aim by: adding general and pandemic-specific self-report measures of stress, and self- collected samples of salivary cortisol to all study visits, including a newly added 12-month follow-up. Aim 2: Determine the feasibility and acceptability of ACT as a telephone-based stress management intervention for PLWH during the COVID-19 pandemic. We will accomplish this aim by modifying our treatment manuals to incorporate COVID-19 related stress, and examining stress-related RCT outcomes by treatment condition. This administrative supplement will provide important information on COVID-related stress among PLWH, and provide data on the feasibility and potential efficacy of telephone-delivered ACT for stress management.
摘要 COVID-19大流行对美国人的心理健康和酒精使用产生了重大影响, 美国的一般人口,并不成比例地影响艾滋病毒感染者(PLWH)。醇 消费和压力都是艾滋病毒治疗中的关键因素,如果不解决,可能会严重影响 有助于进一步传播和不良的治疗相关结果。对艾滋病毒携带者的酒精干预 美国的结果喜忧参半。这种有限成功的一个假设原因是这些失败 解决多重重叠问题的干预措施(例如,共病的心理健康状况,压力, 行为健康需要)的PLWH谁是危险的饮酒者。创新的酒精干预战略, 可以对这些多种行为健康需求产生影响,其形式可以在 在艾滋病毒护理的背景下,特别是在COVID-19大流行的背景下,简短的接受和 承诺疗法(ACT)是一种很有前途的干预艾滋病毒感染的危险饮酒者。行为是一 transdiagnosis治疗,使用正念技能和价值观指导的行为行动计划,以影响一个 一系列的心理症状ACT已显示出治疗焦虑、抑郁、慢性 疼痛和物质使用,因此是一个有前途的方法PLWH谁是危险的饮酒者和应对 新冠肺炎疫情带来额外压力。我们建议扩大我们正在进行的,NIAAA- 资助(R34 AA 026246),试点随机对照试验的电话交付的ACT干预PLWH通过申请 回应有关压力管理的特别关注通知的行政补充文件 COVID-19(NOT-AT-20-011)。此应用程序的总体目标是使用我们正在进行的基础设施 试点随机对照试验(NCT 0397406),以收集PLWH在 COVID-19大流行,并确定随机对照试验的参与者是否在我们的 ACT干预对COVID相关压力的管理有用且适用。具体目标如下: 目标1:将客观和自我报告的压力测量纳入试点RCT。我们将 实现这一目标的方法是:增加一般和特定流行病的自我报告压力措施, 收集所有研究访视的唾液皮质醇样本,包括新增加的12个月随访。目标二: 确定ACT作为电话压力管理干预的可行性和可接受性, 于2019冠状病毒病大流行期间的感染者及病毒携带者。我们将通过修改我们的治疗手册来实现这一目标, 纳入COVID-19相关压力,并按治疗条件检查压力相关RCT结果。这 行政补充将提供艾滋病毒感染者与新冠病毒相关压力的重要信息, 提供数据的可行性和潜在的有效性电话交付的ACT压力管理。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Development of a Telephone-Delivered Acceptance and Commitment Therapy Intervention for People Living with HIV who are Hazardous Drinkers.
  • DOI:
    10.1007/s10461-022-03649-x
  • 发表时间:
    2022-09
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Woolf-King SE;Firkey M;Foley JD;Bricker J;Hahn JA;Asiago-Reddy E;Wikier J;Moskal D;Sheinfil AZ;Ramos J;Maisto SA
  • 通讯作者:
    Maisto SA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN A MAISTO其他文献

STEPHEN A MAISTO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN A MAISTO', 18)}}的其他基金

Clinical Course of Alcohol Use Disorder Recovery
酒精使用障碍康复的临床过程
  • 批准号:
    10585118
  • 财政年份:
    2022
  • 资助金额:
    $ 22.99万
  • 项目类别:
Alcohol and "Heat of the Moment" Sexual Decision Making among MSM: Identifying Mechanisms of Sexual Risk and Promoting Behavior Change Through Brief Intervention
酒精与 MSM 中“一时冲动”的性决策:识别性风险机制并通过简短干预促进行为改变
  • 批准号:
    10684336
  • 财政年份:
    2022
  • 资助金额:
    $ 22.99万
  • 项目类别:
Clinical Course of Alcohol Use Disorder Recovery
酒精使用障碍康复的临床过程
  • 批准号:
    10707414
  • 财政年份:
    2022
  • 资助金额:
    $ 22.99万
  • 项目类别:
Alcohol and "Heat of the Moment" Sexual Decision Making among MSM: Identifying Mechanisms of Sexual Risk and Promoting Behavior Change Through Brief Intervention
酒精与 MSM 中“一时冲动”的性决策:识别性风险机制并通过简短干预促进行为改变
  • 批准号:
    10541644
  • 财政年份:
    2022
  • 资助金额:
    $ 22.99万
  • 项目类别:
Translational Mechanisms of Behavior Change (MOBC) Science
行为改变的转化机制 (MOBC) 科学
  • 批准号:
    10488574
  • 财政年份:
    2021
  • 资助金额:
    $ 22.99万
  • 项目类别:
Brief Acceptance and Commitment Therapy for HIV-Infected At-Risk Drinkers
针对感染艾滋病毒的高危饮酒者的简短接受和承诺疗法
  • 批准号:
    9883696
  • 财政年份:
    2018
  • 资助金额:
    $ 22.99万
  • 项目类别:
Working toward efficacious preventive interventions for alcohol-related HIV/AIDS
致力于针对与酒精相关的艾滋病毒/艾滋病采取有效的预防干预措施
  • 批准号:
    9269935
  • 财政年份:
    2016
  • 资助金额:
    $ 22.99万
  • 项目类别:
Alcohol and Implicit Process in Sexual Risk Behavior in MSM
MSM 性危险行为中的酒精和内隐过程
  • 批准号:
    9269425
  • 财政年份:
    2015
  • 资助金额:
    $ 22.99万
  • 项目类别:
Alcohol and implicit process in sexual risk behavior in MSM
MSM 性危险行为中的酒精和内隐过程
  • 批准号:
    9111782
  • 财政年份:
    2015
  • 资助金额:
    $ 22.99万
  • 项目类别:
Web-based CBT for Substance Misusing and PTSD Symptomatic OEF/OIF Veterans
针对药物滥用和 PTSD 症状 OEF/OIF 退伍军人的基于网络的 CBT
  • 批准号:
    8527631
  • 财政年份:
    2010
  • 资助金额:
    $ 22.99万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 22.99万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 22.99万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 22.99万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 22.99万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 22.99万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 22.99万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 22.99万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 22.99万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 22.99万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 22.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了